Likewise, the LAT1-specific PET probe ^18F-FIMP has been described as a pan-cancer biomarker with high specificity for multiple malignancies, including lung, breast, and colon cancers [28-31], and was recently studied in a series of seven patients with glioblastoma [32]. This evidence concerns the gene SLC7A5 and malignant colon neoplasm.